Sign in
4

Changes in Ownership

Bionano Genomics, Inc. Filed Acc 0001415889-24-015622

Chief Financial Officer acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kama Gulsen · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-03 Grant or award : show line 1 in the form +16,000 16,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/form4-06052024_090604.xml…